Summary
Plasma lipids, lipoproteins and apolipoproteins (apo) were analysed in 30 young Arab IDDM and 50 young insulin-requiring NIDDM women. The mean age of IDDM and NIDDM groups was 20.2 and 34.5 years, and mean duration of diabetes was 5.7 and 4.6 years, respectively. Two groups of 40 and 60 healthy women (matched for age and BMI) provided corresponding control groups. In comparison with control subjects, diabetics showed marked increases in the following parameters: total cholesterol (TC), low density lipoprotein (LDL) cholesterol, total triglycerides (TG), very low density lipoprotein (VLDL) triglycerides, phospholipids, apoB, LDL apoB, glucose and glycosylated hemoglobin (HbA1c) as well as the ratios of total cholesterol/high density lipoprotein (HDL) cholesterol, LDL-cholesterol/HDL-cholesterol, LDL cholesterol/high density lipoprotein 2 (HDL2) cholesterol and apoB/apoAI. Plasma LCAT activity, concentrations of HDL3 apoAI and apoAII in plasma and lipoprotein fractions were normal in both the diabetic groups. Levels of C-peptide, HDL, HDL2 and HDL3 cholesterol, plasma apoAI, HDL apoAI and HDL2 apoAI were markedly decreased in the diabetic groups as compared to their corresponding controls. There was no significant correlation between fasting glucose or HbA1c and any of the above parameters. Despite insulin therapy in both the diabetic groups studied, abnormalities in lipids, apoB and apoAI still persisted. Our data suggest a possible higher risk of atherosclerosis in these patients.
Similar content being viewed by others
References
Allain C. C., Poon L. S., Chan C. S. G., Richmond W., Fu P. C.: Enzymatic determination of total serum cholesterol—Clin. Chem.20, 470, 1974.
Al-Muhtaseb N., A-Yuosuf A. R., Abdella N., Fenech F.: Lipoproteins and apolipoproteins in unique group of young non-obese Arab women with NIDDM treated with insulin—Diabet. Care12, 325, 1989.
Avogaro P., Bittolo B., Cazzolato G., Quinci G. B.: Plasma levels of apolipoprotein A-I and apolipoprotein B in human atherosclerosis—Artery4, 385, 1978.
Barrett Connor E., Witztum J. L., Holdbrook M.: A community study of high density lipoproteins in adults non-insulin dependent diabetics—Amer. J. Epidemiol.117, 186, 1983.
Bergman M., Gidez L. I., Eder H. A.: HDL and HDL sub-classes in diabetes—Diabetes31 (Suppl. 2), 14, 1982; Abstract no 56.
Briones E. R., Mao S. T., Palumbo P. J. O., Fullon W. M., Cheoweth W., Kottke A. B.: Analysis of plasma lipids and apolipoproteins in insulin-dependent diabetes—Metabolism133, 42, 1984.
Chase P. H., Glasgow A. M.: Juvenile diabetes and serum lipids and lipoprotein levels— Amer. J. Dis. Child.130, 1113, 1976.
Cheung M. C., Albers J. J.: The measurement of apolipoprotein AI and AII levels in men and women by immunoassay—J. clin. Invest.60, 43, 1977.
Curtiss L. K., Witzum J. L.: Plasma apolipoproteins AI, AII, B, CI and E are glycosylated in hyperglycemic diabetic subjects—Diabetes34, 452, 1985.
Dieplinger H., Kostner G.: The determination of lecithin cholesterol acyltransferase in the clinical laboratory—Clin. Chim. Acta (Amst.)106, 319, 1980.
Eggstein M.: Eine neue Bestimmung der neutralen Fette in Blutserum und Gewebe—Klin. Wschr.44, 267, 1966.
Elkeles R. S., Khan S. R., Nith-thyanan-than R., Seed M., Wynn V.: High density lipoprotein subfraction cholesterol in hyper-triglyceridaemia—Atherosclerosis43, 423, 1982.
Emara M. K.: Acute myocardial infarction in diabetic patients in Kuwait—Saudi Med. J.4, 139, 1983.
Fielding C. J., Shore V. G., Fielding P. E.: A protein cofactor of lecithin cholesterol acyltransferase—Biochem. biophys. Res. Commun.46, 1493, 1972.
Frohlich J., Mcleod R., Hon K.: Lecithin cholesterol acyltransferase (LCAT)—Clin. Biochem. Rev.15, 269, 1982.
Gibbons G. F.: Hyperlipidaemia of diabetes—Clin. Sci.71, 477, 1986.
Gonen B., White B. N., Schonfeld N., Skor G., Miller D. P., Santiago J.: Plasma levels of apolipoprotein with diabetes mellitus. The effect of glycemic control—Metabolism34, 675, 1985.
Graninger W., Schernthaner G., Conca W., Kostner G. M.: Influence of normoglycemia on apolipoproteins, Lp(a) and LCAT activity in type I diabetics. 16th Annual Meeting of the European Society of Clinical Investigation, INSERM, France; 1982; p. 14, Abstract 82.
Havel R. J., Eder H. A., Bragdon J. H.: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum—J. clin. Invest.34, 1345, 1955.
Hollenbeck C. B., Idachen Y. D., Greensfield M. S., Lardinois C. K., Reaven G. M.: Reduced plasma HDL-cholesterol concentration need not increase when hyperglycemia is controlled insulin in NIDDM—J. clin. Endocrinol. Metabol.63, 605, 1986.
Jarrett R. J., Keen H., Chakrabarti R.: Diabetes, hyperglycemia and arterial disease. In:Jarrett R. J., Keen H. (Eds): Complication of Diabetes. 2nd Ed. Edward Arnold, London, 1982; p. 179.
Kalevi P.: Diabetes and coronary heart disease—Acta Endocrinol.110 (Suppl. 272), 11, 1985.
Kissebah A. H., Alfarsi S., Evans D. J., Adams P. W.: Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein B kinetics in non-insulin-dependent diabetes mellitus—Diabetes31, 217, 1982.
Laakso M., Kalevi P., Erkki V., Jukka M.: Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects—Amer. J. Epidemiol.125, 611, 1987.
Laakso M., Voutilainen E., Sarlund H., Aro A., Pyorala K., Penttila I.: Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin treated diabetics —Metabolism34, 715, 1985.
Laakso M., Voutilainen E., Sarlund H., Aro A., Pyorala K., Penttila I.: Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetes—Atherosclerosis56, 271, 1985.
Lees R. S.: Immunoassay of plasma low density lipoproteins—Science169, 493, 1970.
Lish H. J., Sailor S.: Lipoprotein patterns in diet, sulphonylurea and insulin treated diabetics— Diabetologia20, 118, 1981.
Lopes-Virella M. F., Wohltmann H. J., Loadholt C. B., Buse M. G.: Plasma lipids and lipoproteins in young insulin-dependent-diabetic patients: relationship with control—Diabetologia21, 216, 1981.
Lopes-Virella M. F., Wohltmann H. J., Mayfield R. K., Loadholt C. B., Colwell A.: Effect of metabolic control on lipid, lipoprotein and apolipoprotein levels in 55 insulin-dependent diabetic patients—Diabetes32, 20, 1983.
Madsbad S., Krarup T., McNair P., Christiansen C., Faber O. K., Transbøl I., Binder C.: Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus—Acta med. scand.210, 153, 1981.
Misra D. P., Staddon G., Misra J., Cook D.: Lecithin cholesterol acyltranferase activity in diabetes mellitus and the effect of insulin in these cases—Clin. chim. Acta. (Amst.)56, 83, 1974.
Nikkilä E. A.: High density lipoproteins in diabetes—Diabetes30 (Suppl. 2), 82, 1981.
Nikkilä E. A.: Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes? —Acta endocrinol.110 (Suppl. 272), 27, 1985.
Nikkilä E. A., Taskinen M.-R., Sane T.: Plasma high density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism—Amer. Heart J.113, 543, 1987.
Pietri A., Dun F. L., Raskin P.: The effect of improved diabetic control on plasma lipid and lipoprotein levels-A comparison of conventional therapy and continuous subcutaneous insulin infusion—Diabetes29, 1001, 1980.
Radwan M., Massoud A. A. H., Botros M., Ali M. A.: Epidemiology of diabetes mellitus. In:Vannasaeng S., Nitiyanant W., Chandrrapraset S. (Eds): International Symposium on Epidemiology of Diabetes Mellitus, 1986, Bangkok, Thailand. Bangkok, 1987; p. 190.
Rendel M.: C-peptide as clinical assay—Ligand Quart.24, 30, 1979.
Schernthaner G., Kostner G. M., Dieplinger H., Prager R., Muhlhanser I.: Apolipoproteins (AI, AII, B) LP (a) lipoprotein and lecithin. Cholesterol acyltransferase activity in diabetes mellitus—Atherosclerosis49, 277, 1983.
Schonfeld G.: Diabetes, lipoproteins and atherosclerosis—Metabolism.34 (Suppl), 45, 1985.
Schonfeld G., Jacobson D., White N., Santiago J., Gonen B.: Metabolic control and plasma apolipoproteins in diabetic patients—Diabetes31 (Suppl. 2), 14, 1982; Abstract no 328.
Sosenko J. M., Breslow J. L., Miettinen O. S., Gabbay K. H.: Hyperglycemia and plasma lipid levels. A prospective study of young insulin-dependent diabetic patients—New Engl. J. Med.302, 650, 1980.
Takayama M., Itoh S., Nagasaki T., Tanimizu T.: A new enzymatic method for determination of serum choline containing phospholipids—Clin. Chim. Acta (Amst.)79, 93, 1977.
Taskinen M. R., Nikkilä E. A.: Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes—Diabetologia17, 351, 1979.
Tayler K. G., Wright A. D., Carter T. J. N., Valente A. J., Belts S. A., Matthews K. A.: High density lipoprotein cholesterol and apolipoprotein AI levels at diagnosis in patient with non-insulin-dependent diabetes—Diabetologia20, 535, 1981.
Trinder P.: Determination of glucose in blood using glucoseoxidase with an alternative oxygen acceptor—Ann. clin. Biochem.6, 24, 1969.
Walden C. E., Knopp R. H., Wahl P. W., Beach K. W., Strandness E.: Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations—New Engl. J. Med.311, 953, 1984.
Who Expert Committee on Diabetes Mellitus: Technical Report Series No. 646. World Health Organization, 2nd Rep. Geneva, 7, 1980.
Who Study Group: Diabetes Mellitus. Technical Report Series. No. 727. World Health Organization, Geneva, 1985.
Winocour P. H., Ishola M., Durrington P. N., Anderson D. C.: Lipoprotein abnormalities in insulin dependent diabetes mellitus—Lancetii, 1176, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Al-Muhtaseb, N., Al-Yousuf, A.R. & Bajaj, J.S. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women. Acta diabet. lat 28, 61–69 (1991). https://doi.org/10.1007/BF02732115
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02732115